In the Pipeline: Downstream Targets - Cumberland Pharmaceuticals

In the Pipeline: Downstream Targets - Cumberland Pharmaceuticals

Cumberland Pharmaceuticals - An FDA-sponsored Study of Ifetroban for Ambulatory and Non-Ambulatory Patients with Duchenne Muscular Dystrophy